lymphocytic leukemia, chronic
Showing 1 - 25 of 31
Lymphocytic Leukemia, Chronic Trial in Worldwide (Chlorambucil, Venetoclax, Obinutuzumab)
Active, not recruiting
- Lymphocytic Leukemia, Chronic
- Chlorambucil
- +2 more
-
Duarte, California
- +136 more
Dec 22, 2022
Lymphocytic Leukemia, Chronic, Lymphoma, Non Hodgkin Trial in Worldwide (BTCT4465A (Mosunetuzumab) IV, Atezolizumab, BTCT4465A
Recruiting
- Lymphocytic Leukemia, Chronic
- Lymphoma, Non Hodgkin
- BTCT4465A (Mosunetuzumab) IV
- +2 more
-
Duarte, California
- +55 more
Aug 4, 2022
Lymphocytic Leukemia, Chronic, Lymphoma, Small Lymphocytic Trial in Canada, United States (IPI-145 (duvelisib), Obinutuzumab)
Terminated
- Lymphocytic Leukemia, Chronic
- Lymphoma, Small Lymphocytic
- IPI-145 (duvelisib)
- Obinutuzumab
-
La Jolla, California
- +6 more
Mar 15, 2021
Lymphocytic Leukemia, Chronic Trial in United Kingdom, United States (Obinutuzumab, Venetoclax)
Completed
- Lymphocytic Leukemia, Chronic
-
La Jolla, California
- +9 more
Jan 7, 2020
Lymphocytic Leukemia, Chronic Trial in Russian Federation (Chlorambucil, Cyclophosphamide, Fludarabine)
Terminated
- Lymphocytic Leukemia, Chronic
- Chlorambucil
- +3 more
-
Irkutsk, Russian Federation
- +7 more
Nov 23, 2018
Lymphocytic Leukemia, Chronic Trial in Worldwide (Cyclophosphamide, Fludarabine, rituximab [MabThera])
Completed
- Lymphocytic Leukemia, Chronic
- Cyclophosphamide
- +2 more
-
Buenos Aires, Argentina
- +83 more
Nov 17, 2018
Rituximab (MabThera) in Chronic Lymphocytic Leukemia (CLL)
Completed
- Lymphocytic Leukemia, Chronic
-
Frechen, GermanyPIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann
Dec 8, 2017
Lymphocytic Leukemia, Chronic Trial in Worldwide (obinutuzumab, rituximab, chlorambucil)
Completed
- Lymphocytic Leukemia, Chronic
- obinutuzumab
- +2 more
-
San Diego, California
- +261 more
Aug 15, 2018
Lymphocytic Leukemia, Chronic Trial in Worldwide (obinutuzumab, rituximab, chlorambucil)
Completed
- Lymphocytic Leukemia, Chronic
- obinutuzumab
- +2 more
-
San Diego, California
- +261 more
Aug 15, 2018
Lymphocytic Leukemia, Chronic Trial in Worldwide (obinutuzumab, rituximab, chlorambucil)
Completed
- Lymphocytic Leukemia, Chronic
- obinutuzumab
- +2 more
-
San Diego, California
- +261 more
Aug 15, 2018
Lymphocytic Leukemia, Chronic Trial in Belarus, Poland (Cladribine, Cyclophosphamide, Rituximab)
Rituximab in Combination With Chemotherapy in CD20-Positive
Completed
- Lymphocytic Leukemia, Chronic
-
Alexandroupolis, Greece
- +8 more
Apr 5, 2018
Lymphocytic Leukemia, Chronic Trial in Israel (Cyclophosphamide, Fludarabine, Rituximab)
Completed
- Lymphocytic Leukemia, Chronic
- Cyclophosphamide
- +2 more
-
Afula, Israel
- +11 more
Apr 18, 2018
Lymphocytic Leukemia, Chronic Trial in Russian Federation (Cyclophosphamide, Fludarabine, Rituximab)
Terminated
- Lymphocytic Leukemia, Chronic
- Cyclophosphamide
- +2 more
-
Irkutsk, Russian Federation
- +9 more
Aug 22, 2017
Lymphocytic Leukemia, Chronic Trial in Austria (rituximab [MabThera/Rituxan], fludarabine, cyclophosphamide)
Completed
- Lymphocytic Leukemia, Chronic
- rituximab [MabThera/Rituxan]
- +2 more
-
Innsbruck, Austria
- +7 more
Jul 11, 2017
Lymphocytic Leukemia, Chronic Trial in Italy (rituximab [MabThera/Rituxan], chlorambucil)
Completed
- Lymphocytic Leukemia, Chronic
- rituximab [MabThera/Rituxan]
- chlorambucil
-
Catanzaro, Calabria, Italy
- +19 more
Jul 6, 2017
Leukemia, Myeloid, Acute, Leukemia, Myelogenous, Chronic, Leukemia, Lymphoblastic, Acute Trial in Saint Louis (AMD3100, Stem
Completed
- Leukemia, Myeloid, Acute
- +7 more
- AMD3100
- Stem Cell Transplant
-
Saint Louis, MissouriWashington University School of Medicine
Jun 5, 2017
Lymphocytic Leukemia, Chronic Trial in United States (Obinutuzumab, Corticosteroids)
Completed
- Lymphocytic Leukemia, Chronic
-
Birmingham, Alabama
- +30 more
Mar 20, 2017
MabThera/Rituxan in Relapsing or Refractory Chronic Lymphocytic
Completed
- Lymphocytic Leukemia, Chronic
-
Aix En Provence, France
- +83 more
Mar 21, 2017
Multiple Myeloma, Lymphocytic Leukemia, Chronic, Lymphoma, Low-Grade Trial in Ann Arbor (Reduced intensity conditioning, Rapid
Completed
- Multiple Myeloma
- +2 more
- Reduced intensity conditioning
- +2 more
-
Ann Arbor, MichiganThe University of Michigan
Jan 18, 2017
Lymphoma, Small Lymphocytic, Lymphocytic Leukemia, Chronic Trial in Columbus (Fludarabine, Rituximab, Alemtuzumab)
Completed
- Lymphoma, Small Lymphocytic
- Lymphocytic Leukemia, Chronic
- Fludarabine
- +2 more
-
Columbus, OhioOhio State University
Feb 6, 2017
Lymphocytic Leukemia, Chronic Trial in United States (Fludarabine, Obinutuzumab, Bendamustine)
Completed
- Lymphocytic Leukemia, Chronic
- Fludarabine
- +3 more
-
Huntsville, Alabama
- +17 more
Dec 8, 2016
The Health Related Quality of Life in Chronic Lymphocytic
Completed
- Lymphocytic Leukemia, Chronic
-
Bournemouth, United Kingdom
- +4 more
Nov 1, 2016
MabThera/Rituxan in Combination With Chemotherapy in B
Completed
- Lymphocytic Leukemia, Chronic
- Chemotherapy
- rituximab [MabThera/Rituxan]
-
Vitoria, Alava, Spain
- +54 more
Nov 1, 2016